Single Patient Use of Selinexor and Dexamethasone for a Patient With Multiple Myeloma

Sponsor
Masonic Cancer Center, University of Minnesota
Study ID
NCT03850704
Status
No Longer Available

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

This is an individual patient, expanded access protocol using Selinexor and dexamethasone ("Sd") for the treatment of Relapsed, Refractory multiple myeloma in a 64 year old male, "19023-UMN-01" weighing 105.7 kg. 19023-UMN-01 has IgG kappa myeloma that has relapsed after numerous treatments.

Key Dates

Status verified
Feb 2019

Related Studies